PPIDT00268

Drug Information
NameMethoxy polyethylene glycol-epoetin beta
SequenceNot Available
DrugBank_IDDB09107
Typebiotech
IndicationFor the treatment of patients with anaemia associated with chronic kidney disease. Not a substitute for RBC transfusion if immediate correction of anemia is required.

Dosage Forms
Form Route Strength
Injection, solution Intravenous
100 ug/0.3mL
Injection, solution Intravenous
120 ug/0.3mL
Injection, solution Intravenous
150 ug/0.3mL
Injection, solution Intravenous
200 ug/0.3mL
Injection, solution Intravenous
250 ug/0.3mL
Injection, solution Intravenous
30 ug/0.3mL
Injection, solution Intravenous
360 ug/0.6mL
Injection, solution Intravenous
50 ug/0.3mL
Injection, solution Intravenous
75 ug/0.3mL
Injection, solution Intravenous; Subcutaneous
100 MCG
Injection, solution Intravenous; Subcutaneous
100 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
1000 MCG
Injection, solution Intravenous; Subcutaneous
120 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
120 MCG/0.3ML
Injection, solution Intravenous; Subcutaneous
150 MCG
Injection, solution Intravenous; Subcutaneous
150 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
200 MCG
Injection, solution Intravenous; Subcutaneous
200 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
250 MCG
Injection, solution Intravenous; Subcutaneous
250 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
30 MCG/0.3ML
Injection, solution Intravenous; Subcutaneous
30 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
300 MCG
Injection, solution Intravenous; Subcutaneous
360 ug/0.6ml
Injection, solution Intravenous; Subcutaneous
360 MCG/0.3ML
Injection, solution Intravenous; Subcutaneous
40 MCG/0.3ML
Injection, solution Intravenous; Subcutaneous
40 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
400 MCG
Injection, solution Intravenous; Subcutaneous
50 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
50 MCG
Injection, solution Intravenous; Subcutaneous
60 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
60 MCG/0.3ML
Injection, solution Intravenous; Subcutaneous
600 MCG
Injection, solution Intravenous; Subcutaneous
75 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
75 MCG
Injection, solution Intravenous; Subcutaneous
800 MCG
Solution Intravenous; Subcutaneous
100 mcg / 0.3 mL
Solution Intravenous; Subcutaneous
100 mcg / mL
Solution Intravenous; Subcutaneous
1000 mcg / mL
Solution Intravenous; Subcutaneous
150 mcg / 0.3 mL
Solution Intravenous; Subcutaneous
200 mcg / 0.3 mL
Solution Intravenous; Subcutaneous
200 mcg / mL
Solution Intravenous; Subcutaneous
250 mcg / 0.3 mL
Solution Intravenous; Subcutaneous
300 mcg / mL
Solution Intravenous; Subcutaneous
400 mcg / mL
Solution Intravenous; Subcutaneous
400 mcg / 0.6 mL
Solution Intravenous; Subcutaneous
50 mcg / 0.3 mL
Solution Intravenous; Subcutaneous
50 mcg / mL
Solution Intravenous; Subcutaneous
600 mcg / 0.6 mL
Solution Intravenous; Subcutaneous
600 mcg / mL
Solution Intravenous; Subcutaneous
75 mcg / 0.3 mL
Solution Parenteral
50.000 mcg
Injection, solution Intravenous; Subcutaneous
100 mcg/mL
Injection, solution Parenteral
100 UG/0.3ML
Injection, solution Parenteral
100 ug/0.3ml
Injection, solution Parenteral
120 UG/0.3ML
Injection, solution Parenteral
120 ug/0.3ml
Injection, solution Parenteral
150 UG/0.3ML
Injection, solution Parenteral
150 ug/0.3ml
Injection, solution Parenteral
200 UG/0.3ML
Injection, solution Parenteral
200 ug/0.3ml
Injection Intravenous; Subcutaneous
Injection, solution Parenteral
250 UG/0.3ML
Injection, solution Parenteral
250 ug/0.3ml
Injection, solution Parenteral
30 UG/0.3ML
Injection, solution Parenteral
30 ug/0.3ml
Injection, solution Intravenous; Subcutaneous
Injection, solution Parenteral
360 UG/0.6ML
Injection, solution Parenteral
360 ug/0.3ml
Injection, solution Parenteral
50 UG/0.3ML
Injection, solution Parenteral
50 ug/0.3ml
Injection, solution Parenteral
75 UG/0.3ML
Injection, solution Parenteral
75 ug/0.3ml
Injection Intravenous; Subcutaneous
800 mcg
Solution Intravenous; Subcutaneous
3000000 mcg
Injection, solution Intravenous; Subcutaneous
100 mcg/0.3ml
Injection, solution Intravenous; Subcutaneous
50 mcg/0.3ml
Injection, solution Intravenous; Subcutaneous
75 mcg/0.3ml
Solution Intravenous; Subcutaneous
200 MCG/0.3ML
Solution Intravenous; Subcutaneous
250 MCG/0.3ML
Solution Intravenous; Subcutaneous
30 mcg/0.3mL
Solution Intravenous; Subcutaneous
360 mcg/0.6mL
Solution Intravenous; Subcutaneous
800 MCG/0.6ML
Solution Intravenous; Subcutaneous
10000000 mcg
Solution Intravenous; Subcutaneous
15000000 mcg
Solution Intravenous; Subcutaneous
250 cg
Solution Intravenous; Subcutaneous
50 cg
Solution Intravenous; Subcutaneous
100 cg
Solution Intravenous; Subcutaneous
1000 cg
Solution Intravenous; Subcutaneous
200 cg
Solution Intravenous; Subcutaneous
0.3 mg
Solution Intravenous; Subcutaneous
120 cg
Solution Intravenous; Subcutaneous
100 mcg/0.3ml
Solution Intravenous; Subcutaneous
120 mcg/0.3ml
Solution Intravenous; Subcutaneous
150 mcg/0.3ml
Solution Intravenous; Subcutaneous
50 mcg/0.3ml
Solution Intravenous; Subcutaneous
75 mcg/0.3ml
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P19235 EPOR Erythropoietin receptor Homo sapiens stimulator Link